Private equity firm KCGI acquires 25% of LIG for $84 mil Deal includes call option for majority shareholders and drag along right for KCGI
Translated by Ryu Ho-joung 공개 2022-01-13 08:11:09
이 기사는 2022년 01월 13일 08:07 thebell 에 표출된 기사입니다.
KCGI, a Seoul-based private equity firm, has recently acquired a 25% stake in LIG Corp for 100 billion won ($84 million) from Koo Bon-sang, the holding company’s chairman, and his younger brother Koo Bon-yeop, according to sources.The deal included a call option that allows the Koo brothers to buy KCGI's stake three years later at a price that provides the private equity firm with a certain rate of return.
At the same time, the shareholder agreement provided KCGI with a drag along right that will enable the private equity firm to sell its stake to a third party and force the Koo brothers to join the sale if LIG Corp fails to go public within an agreed upon period of time.
LIG Corp’s subsidiaries include defense company LIG Nex1, software company LIG System and facility management company Huseco. Especially, LIG Nex1’s growth has been accelerated in recent years, helping to boost the value of its parent company.
However, the Koo brothers, who are LIG Corp's largest shareholders, are facing criminal charges that they evaded 133 billion won in taxes when they raised their stakes in the holding company several years ago by mispricing shares.
Prosecutors sought a prison term of 10 years and eight years, respectively, for Koo Bon-sang and Koo Bon-yeop in November last year, with the court’s ruling expected later this month. Many legal experts expect the defendants to appeal, which could lead to years of legal fight.
This could delay LIG Corp’s potential listing on the stock exchange because the Korea Exchange wouldn’t give the green light to a company whose majority shareholders have legal issues.
In a worst case scenario, if the company fails to go public by the agreed upon deadline, KCGI could opt to exercise a drag along right, which could threaten the Koo brothers’ control over LIG Corp. (Reporting by Se-hun Jo)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '오리온 파트너' 하이센스바이오, 기평 신청 'IPO 재도전'
- ['빅바이오텍의 꿈' 프레스티지는 지금]글로벌 체급 맞춘 과감한 투자 "도약의 시점, 두려움 없다"
- [온코크로스 IPO In-depth]신약 한방 아닌 플랫폼 통한 성장, 이미 확보된 고객·매출
- [오름테라퓨틱 IPO In-depth]상장 앞두고 바뀐 이사회, 그래도 막강한 전임 CSO 영향력
- 현신균 LG CNS 사장 승진, 'IPO 완수' 중책
- 노보노디스크 '韓 협업' 시동 "플랫폼까지 관심 영역 확장"
- [코스닥 상장사 매물 분석]외형 줄어든 디티씨, 루멘스 인수 돌파구 기대
- [Company Watch]'유해사이트 차단' 플랜티넷, 3분기 실적 개선세 뚜렷
- [현장 인 스토리]세림B&G, 친환경 생분해 플라스틱 도약 준비 '끝'
- 'IPO 출사표' 와이즈넛, 3000억대 몸값 제시 '투심 관건'